Clin2
NCT07319949Likely a fitNot yet recruiting

Tumor origin test for metastatic cancer patients

Malignant Tumor With MetastasisCUP

Part of Cancer clinical trials.

This trial uses a genetic test on a sample from your metastatic tumor to help identify where your cancer started. It may help guide your treatment decisions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
Any age
Study type
Observational

Who can take part

  • You have been diagnosed with cancer that has spread to another part of your body.
  • The metastatic tumor has been confirmed as cancer through a biopsy.
  • You have enough leftover tumor tissue from a past surgery or biopsy for genetic testing.
  • You (or your legal guardian) understand the study and agree to take part.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06695494Recruiting
Genomic testing for cancer of unknown primary

This trial is for people with cancer of unknown primary (CUP), meaning cancer that started in an unknown place in the body. It aims to use advanced genomic testing (looking at your tumor's DNA) on your stored tumor sample and blood to find clues about where the cancer began and possible treatment options.

Manchester, Greater Manchester
NCT02215928Recruiting
Using tumor genetic tests to guide treatment choices

This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.

Palo Alto, California
NCT01774409Recruiting
Genetic and immune testing program for advanced cancers

This program gathers tumor samples to study their genetic and immune (immune-system) features across many types of advanced cancer. Your information and tumor testing may help researchers understand which tumor features are present and how they relate to cancer behavior.

Annecy
NCT02155621Recruiting
Personalized gene testing to guide cancer treatment choices

This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.

Vancouver, British Columbia
NCT02090530Recruiting
Precision testing of tumor tissue for advanced cancers

This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.

Columbus, Ohio
NCT06140992Recruiting
A trial to classify cancer of unknown primary

This trial is for people whose cancer started in an unknown place (cancer of unknown primary). It uses a special test called PaCIFiC-CUP to help classify the cancer, which may guide better treatment choices.

Guangzhou, Guangdong

Hear when a new Malignant Tumor With Metastasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.